-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 7, two well-known pharmaceutical companies, AstraZeneca and Junshi Biological, received new news about internal changes, related to structural adjustments and related personnel changes.
AZ organizational structure adjustment
AZ organizational structure adjustmentAccording to relevant media, AstraZeneca China announced the adjustment of its organizational structure, formally merged the existing digestion and respiratory nebulization business, established the digestion and respiratory nebulization business unit (GNR), appointed Chen Pengquan as the general manager, under the jurisdiction of marketing, sales, new Product planning and strategic marketing team
Qian Wei appointed as Chief Commercial Officer of Junshi Bio
Qian Wei appointed as Chief Commercial Officer of Junshi BioAt the same time, the media also said that it had recently received news about Junshi Bio.
After Qian Wei joins, he will be fully responsible for the management of Junshi Bio's sales team, strategic marketing department, marketing department, oncology product medical affairs department, sales training department, etc.
Source: Medical representative
Source: Medical representative